NOTE 4:–

STOCKHOLDERS’ EQUITY (DEFICIENCY)

On December 30, 2005, the Company’s board of directors adopted the Varonis Systems, Inc. 2005 Stock Plan (the “2005 Stock Plan”). As of December 31, 2013, the Company had reserved 4,713,319 shares of common stock available for issuance to employees, directors, officers and consultants of the Company and its subsidiaries. As of December 31, 2013, the Company granted options with respect to 4,656,855 shares of common stock under the 2005 Stock Plan. The options generally vest over four years. No awards were granted under the 2005 Stock Plan subsequent to December 31, 2013, and no further awards will be granted under the 2005 Stock Plan.

On November 14, 2013, the Company’s board of directors adopted the Varonis Systems, Inc. 2013 Omnibus Equity Incentive Plan (the “2013 Plan”). As of March 31, 2014, the Company had reserved 1,904,633 shares of common stock available for issuance under the 2013 Plan to employees, directors, officers and consultants of the Company and its subsidiaries. The number of shares of common stock available for issuance under the 2013 Plan will be increased on January 1, 2016 and on each January 1 thereafter by four percent (4%) of the number of shares of common stock issued and outstanding on each December 31 immediately prior to the date of increase (rounded down to the nearest whole share), but the amount of each increase will be limited to the number of shares of common stock necessary to bring the total number of shares of Common Stock available for grant and issuance under the 2013 Plan to five percent (5%) of the number of shares of common stock issued and outstanding on each December 31. Options granted under the 2013 Plan generally vest over four years. Any award that is forfeited or canceled before expiration becomes available for future grants under the 2013 Plan.

A summary of employees’ stock options activities during the period ended March 31, 2014 is as follows:


	Period ended March 31, 2014 (unaudited)
	Number			Average exercise price		Aggregate intrinsic value (in thousands)		Average remaining contractual life (years)

Options outstanding at the beginning of the year		3,233,235		$	4.033	$	65,723		5.700
Granted		214,650		$	39.860
Exercised		(10,875	)	$	1.282
Forfeited		(8,752	)	$	12.845


Options outstanding at the end of the period		3,428,258		$	6.264	$	102,001		5.729


Vested and expected to vest		3,378,232		$	6.034	$	101,244		5.676


Options exercisable at the end of the period		2,581,849		$	1.582	$	88,242		4.602

The aggregate intrinsic value in the table above represents the total intrinsic value that would have been received by the option holders had all option holders exercised their options on the last date of the exercise period. Total intrinsic value of options exercised for the three month period ended March 31, 2014 was $251. As of March 31, 2014 there was $10,364 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the 2005 Stock Plan and 2013 Plan. This cost is expected to be recognized over a period of approximately 3.4 years.

The options outstanding as of March 31, 2014 (unaudited) have been separated into ranges of exercise price as follows:


Range of exercise price	Options outstanding as of March 31, 2014		Weighted average remaining contractual life (years)		Weighted average exercise price		Options exercisable as of March 31, 2014		Weighted average remaining contractual life (years)		Weighted average exercise price of options exercisable

$0.070-0.901		758,047		3.120	$	0.744		758,047		3.120	$	0.744
$1.039-1.576		1,672,067		4.959	$	1.260		1,657,236		4.946	$	1.257
$6.230-8.800		182,773		7.628	$	6.709		112,294		7.544	$	6.775
$12.470		439,971		8.927	$	12.470		54,272		8.709	$	12.470
$21.14-24.23		160,750		9.440	$	21.991		—		—	$	—
$39.86		214,650		9.981	$	39.860		—		—	$	—


		3,428,258		5.729	$	6.264		2,581,849		4.602	$	1.582

The fair value of stock option grants for the period ended March 31, 2014 was estimated using the following weighted average assumptions:


	Period ended March 31, 2014
	Unaudited

Expected dividend yield		0	%
Expected volatility		60	%
Risk-free interest rate		2.30	%
Expected term (years)		6.25

Options issued to consultants:

The Company’s outstanding options granted to consultants for sales and pre-marketing services as of March 31, 2014 (unaudited) were as follows:


	Options for shares of common stock		Exercise price per share		Options exercisable		Exercisable through
	(number)				(number)

December 2006		40,090	$	0.901		40,090	December 2016
May 2012		687	$	6.800		687	May 2022
February 2013		4,000	$	12.470		1,083	February 2023
August 2013		5,000	$	21.140		—	August 2023
October 2013		1,250	$	24.230		—	October 2023
March 2014		18,850	$	39.860		—	March 2024


		69,877				41,860

Stock-based compensation expense for employees and consultants:

The Company recognized non-cash stock-based compensation expense in the consolidated statements of operations as follows (in thousands):


	Three Months Ended March 31,
	2014		2013
	(unaudited)
	(In thousands)

Cost of revenues	$	20	$	6
Research and development		199		59
Sales and marketing		340		66
General and administrative		87		63


Total	$	646	$	194